STAA · NASDAQ
STAAR Surgical (STAA) Stock Price & Fundamentals
STAAR Surgical (STAA) closed at $567.64 on Oct 9, 2026, up 0.11% from the previous close of $567.02.
Share price, past year
1Y +10.67%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $567.64 |
| Sep 30, 2026 | $556.16 |
| Aug 31, 2026 | $561.46 |
| Jul 31, 2026 | $567.40 |
| Jun 30, 2026 | $553.76 |
| May 29, 2026 | $516.13 |
| Apr 30, 2026 | $531.49 |
| Mar 31, 2026 | $490.62 |
| Feb 27, 2026 | $497.40 |
| Jan 30, 2026 | $504.88 |
| Dec 31, 2025 | $520.16 |
| Nov 28, 2025 | $524.19 |
| Oct 31, 2025 | $526.99 |
Key statistics
- Market cap
- $28.45B
- P/E (TTM)
- 7,095.5
- EPS (TTM)
- $0.08
- Revenue (TTM)
- $339.59M
- Net income (TTM)
- $3.84M
- Shares outstanding
- 50.1M
- Dividend yield
- —
- 52-week range
- $479.75 – $573.28
STAAR Surgical's market cap is $28.45B, based on a share price of $567.64 and 50.1M shares outstanding as of Jul 3, 2026.
Financials
STAAR Surgical reported revenue of $239.44M for fiscal 2025.
STAAR Surgical reported a net loss of $80.45M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Jan 2, 2026 | $239.44M | −23.7% | −$80.45M | −33.6% | −$1.62 | −$40.05M |
| FY2023ended Dec 27, 2024 | $313.90M | −2.6% | −$20.21M | −6.4% | −$0.41 | −$7.67M |
| FY2022ended Dec 29, 2023 | $322.42M | +34.7% | $21.35M | 6.6% | $0.43 | −$3.59M |
| FY2021ended Dec 30, 2022 | $239.44M | +3.9% | $39.67M | 16.6% | $0.80 | $17.61M |
| FY2020ended Dec 31, 2021 | $230.47M | +41.0% | $27.51M | 11.9% | $0.56 | $30.32M |
| FY2020ended Jan 1, 2021 | $163.46M | +8.8% | $27.51M | 16.8% | $0.56 | $30.32M |
| FY2019ended Jan 3, 2020 | $150.19M | +21.2% | $14.05M | 9.4% | $0.30 | $15.70M |
| FY2017ended Dec 28, 2018 | $123.95M | +36.8% | $4.97M | 4.0% | $0.11 | $10.52M |
| FY2016ended Dec 29, 2017 | $90.61M | +9.9% | −$2.14M | −2.4% | −$0.05 | $1.81M |
| FY2016ended Dec 30, 2016 | $82.43M | — | −$2.14M | −2.6% | −$0.05 | $1.81M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jul 3, 2026 | $93.54M | $8.06M | $0.16 |
| Q1 FY2026ended Apr 3, 2026 | $93.52M | $5.21M | $0.10 |
| Q4 FY2025ended Jan 2, 2026 | $57.80M | −$18.31M | −$0.36 |
| Q3 FY2025ended Sep 26, 2025 | $94.73M | $8.88M | $0.18 |
| Q2 FY2025ended Jun 27, 2025 | $44.32M | −$16.81M | −$0.34 |
| Q1 FY2025ended Mar 28, 2025 | $42.59M | −$54.21M | −$1.10 |
| Q4 FY2023ended Dec 27, 2024 | $48.95M | −$34.23M | — |
| Q3 FY2023ended Sep 27, 2024 | $88.59M | $9.98M | $0.20 |
Company profile
- Name
- STAAR Surgical Company
- Ticker
- STAA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Ophthalmic Goods
- Headquarters
- 1911 Walker Ave, Monrovia, CA 91016
- Incorporated in
- DE
- Fiscal year ends
- January
- SEC CIK
- 0000718937
Recent SEC filings
- Sep 10, 2026
- Aug 12, 2026
- Aug 12, 2026
- Aug 6, 2026
- Jun 22, 2026
- Jun 9, 2026
- May 13, 2026
- May 13, 2026
Frequently asked questions
What is STAAR Surgical's stock price?
STAAR Surgical (STAA) closed at $567.64 on Oct 9, 2026, up 0.11% from the previous close of $567.02.
What is STAAR Surgical's market cap?
STAAR Surgical's market cap is $28.45B, based on a share price of $567.64 and 50.1M shares outstanding as of Jul 3, 2026.
How much revenue does STAAR Surgical make?
STAAR Surgical reported revenue of $239.44M for fiscal 2025.
What is STAA's P/E ratio?
STAAR Surgical's price-to-earnings ratio is 7,095.5, based on trailing twelve-month diluted EPS of $0.08.
Does STAAR Surgical pay a dividend?
STAAR Surgical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from STAAR Surgical Company's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures